Kevin is the founder and CEO of Medicinal Genomics Corporation. Medicinal Genomics made world-wide news in 2011 when it publicly released the first genome sequence for Cannabis sativa L. As a result of this work, Medicinal Genomics (MGC) launched a suite of qPCR tools for the detection of microbial contamination on Cannabis. Prior to Medicinal Genomics, Kevin was the team leader of R&D for the human genome project at Whitehead Institute/MIT Center for Genome Research. This work led to the foundation of Agencourt Bioscience corporation which was acquired by Beckman Coulter and Agencourt Personal Genomics that was acquired by Applied Biosystems for development of the SOLiD Sequencer.